Company Search:
Advanced Search
Sponsored Links
Virbac Company Snapshot
Virbac operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other companies in this sector in FRANCE : Boiron SA (2019 sales of 557.12 million Euro [US$656.99 million] of which 53% was OTC Specialities and Other Products), Guerbet SA (816.91 million Euro [US$963.34 million] of which 46% was X-rays), and Vetoquinol Sa (395.99 million Euro [US$466.97 million] of which 53% was Europe).

Sales Analysis. Virbac reported sales of 938.34 million Euro (US$1.11 billion) for the year ending December of 2019. This represents an increase of 8.0% versus 2018, when the company's sales were 868.93 million Euro. Sales of Other Activities saw an increase of 11.8% in 2019, from 11.00 million Euro to 12.30 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Virbac
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 184.60
(Figures in Euros )
1 Week -2.9%   13 Weeks -8.8%  
4 Weeks 2.6%   52 Weeks 11.7%  
Virbac Key Data:
  Ticker: VIRP Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 938,342,000
(Year Ending Jan 2020).
Employees: 4,897
  Currency: Euros Market Cap: 1,556,514,341
  Fiscal Yr Ends: December Shares Outstanding: 8,431,822
  Share Type: Actions Ordinaires Closely Held Shares: 4,267,404
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.